Laboratorio Reig Jofre S.A. Logo

Laboratorio Reig Jofre S.A.

A pharmaceutical company making essential health products accessible in over 70 countries.

RJF | MC

Overview

Corporate Details

ISIN(s):
ES0165359029
LEI:
9598003MRMJHA81QJF20
Country:
Spain
Address:
Gran Capità 10, 08970 Sant Joan Despí
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Reig Jofre S.A., established in 1929, is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, food supplements, and nutritional cosmetics. The company operates four development and production centers in Europe, supporting its global distribution network which spans over 70 countries through subsidiaries and business partners. With a focus on technological specialization, Reig Jofre is dedicated to making essential health products accessible worldwide. The company employs over 1,100 people to support its international operations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 11:36
Notice of Dividend Amount
Reig Jofre informa sobre el inicio del Scrip Dividend
Spanish 168.7 KB
2025-05-09 07:59
Share Issue/Capital Change
Reig Jofre remite las condiciones y el informe del Scrip Dividend
Spanish 454.9 KB
2025-05-09 07:48
Board/Management Information
Reig Jofre informa del cambio de Secretario no Consejero del Consejo de Adminis…
Spanish 150.2 KB
2025-05-09 07:44
Quarterly Report
Reig Jofre remite nota de prensa sobre los resultados del primer trimestre de 2…
Spanish 528.9 KB
2025-05-09 07:43
Investor Presentation
Reig Jofre presenta los resultados del primer trimestre de 2025
Spanish 4.6 MB
2025-05-08 19:43
Capital/Financing Update
Reig Jofre remite nota de prensa sobre la subvención obtenida del CDTi para imp…
Spanish 476.0 KB
2025-04-09 18:17
Post-Annual General Meeting Information
Reig Jofre remite los acuerdos adoptados en la Junta General de Accionistas de …
Spanish 160.4 KB
2025-04-04 01:28
Transaction in Own Shares
Reig Jofre informa de las operaciones realizadas durante el primer trimestre de…
English 705.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-02-28 14:18
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 177.5 KB
2025-02-28 14:15
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 386.7 KB
2025-02-28 07:33
Earnings Release
Reig Jofre remite nota de prensa sobre los resultados de 2024
Spanish 867.1 KB
2025-02-28 07:31
Investor Presentation
Reig Jofre presenta los resultados de 2024
Spanish 1.9 MB

Automate Your Workflow. Get a real-time feed of all Laboratorio Reig Jofre S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Reig Jofre S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Reig Jofre S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
GALECTIN THERAPEUTICS INC Logo
Developing galectin-3 inhibitors for MASH cirrhosis, fibrosis, and cancer.
United States of America GALT
Galecto, Inc. Logo
Develops novel small molecule drugs targeting cancer and severe fibrotic diseases.
United States of America GLTO
Galmed Pharmaceuticals Ltd. Logo
Develops oral therapeutics for liver, metabolic, and inflammatory diseases like NASH.
United States of America GLMD
GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea 144510
Gelteq Ltd Logo
Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.
United States of America GELS
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea 082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea 229000
GENELUX Corp Logo
Developing oncolytic viral immunotherapies for difficult-to-treat cancers using a vaccinia virus.
United States of America GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea 109820

Talk to a Data Expert

Have a question? We'll get back to you promptly.